Inherited eye disease sees first FDA-approved gene therapy in Luxturna
Inherited eye disease sees first FDA-approved gene therapy in Luxturna
CLEVELAND, Ohio -- Allison Corona remembers every detail about the night in 2005 when she discovered that there might be a cure for her blindness.
She was up late doing research on her computer – with the screen ...
Scientists Use Gene Therapy to Fight HIV
- The AdvocateStamford cancer nonprofit seeks to raise national profileJanuary 21, 2019
- Watertown Daily TimesGene therapy offers hope to people with achromatopsia, an inherited retinal eye diseaseNovember 30, 2018
- The News-TimesPharma BI joins forces against cystic fibrosisAugust 7, 2018
- Houston ChronicleThe free market is curing blindnessJune 24, 2018
Designer proteins that package genetic material could help deliver gene therapy
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Ian Haydon, University of ...
University of Minnesota research was pivotal in landmark gene editing trial
A bold attempt this month to cure a lethal genetic disease by editing DNA inside a patient was carried out in San Francisco and made headlines around the country but it was based largely on mouse research at the University of Minnesota Medical Center.
Now, the second, third and additional ...
- Globe NewswireLysogene and Sarepta Therapeutics Announce Dosing of the First Patient in AAVance, a Phase 2/3 Clinical Trial Investigating LYS-SAF302, a Gene Therapy for the Treatment of MPS IIIA (Sanfilippo Syndrome Type A)February 14, 2019
- Business WireGlobal Interstitial Cystitis Drugs Market Outlook, 2019-2023 - Advent of Gene Therapy to Drive Market Growth - ResearchAndMarkets.comFebruary 14, 2019
- Globe NewswireAdverum to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceFebruary 13, 2019
- Business WirePAREXEL Appoints Former FDA Senior Executives to Global Regulatory Consulting ServicesFebruary 12, 2019
- Globe NewswireAdverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration ConferenceFebruary 11, 2019
Abeona Therapeutics announces new gene therapy facility, stock offering
Abeona Therapeutics announces new gene therapy facility, stock offering
CLEVELAND, Ohio -- Like a World Series team on a streak, Cleveland-based Abeona Therapeutics Inc. got hot in October.
Abeona Therapeutics is a clinical-stage biopharmaceutical company developing gene and cell ...
‘Molly is a success story’: Gene therapy that improved Nebraska teen’s vision could soon be available nationwide
OMAHA, Neb. — The first new thing Molly Troxel saw was a familiar sight — some might even say an old friend — to most other people.
“I saw the moon,” she said. “I’d never seen it before.”
Then came more firsts: her dog’s eyelashes; the twinkle lights in the boutique next door to the ...
‘Molly is a success story’: Gene therapy that improved Omaha teen’s vision could soon be available nationwide
The first new thing Molly Troxel saw was a familiar sight — some might even say an old friend — to most other people.
“I saw the moon,” she said. “I’d never seen it before.”
Then came more firsts: her dog’s eyelashes; the twinkle lights in the boutique next door to the pizza ...